A photo that shows the Swiss pharmaceutical giant logo in Basel.
Sebastien Bozon | AFP | Getty images
Swiss pharmaceutical giant Roche On Tuesday, he said he would invest $ 50 billion in the US.
The investment will create more than 12,000 jobs, Roche said: 1,000 with the company and the rest to support the new manufacturing capabilities of the United States.
The pharmaceutical giant will inject effective in the creation of new generation research and development sites (R&D), while reinforcing and expanding manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California. A new R&D site in Massachusetts will be used for AI investigation and will act as a center for the research of cardiovascular, renal and metabolism treatments.
The financing package will also be used to build a new 900,000 square feet manufacturing center in an unknown location to support the “portfolio expansion of the next -generation weight” medications.
Once the new manufacturing capacity investments are completed, Roche said that more US medications would export. UU. Than imports.
Pharmaceutical companies have been fighting to reinforce their presence from the United States amid threats from President Donald Trump to end the exemption of the import rate industry.
“We are going to announce very soon an important rate about pharmaceutical products,” he said earlier this month.
This developing story is being updated.